Genelux Corporation

3030 Bunker Hill Street
Suite 310
San Diego
United States

Tel: 858-483-0024


Show jobs for this employer

About Genelux Corporation

Genelux Corporation is a privately-held, Phase 2 clinical stage biopharmaceutical company headquartered in San Diego, California. We have developed a broadly-diversified technology platform and a deep pipeline of proprietary oncology products based upon cancer-colonizing microorganisms, particularly oncolytic vaccinia virus. Our clinical program is advancing an oncolytic immunotherapy platform; GL-ONC1, the Company's lead candidate, currently is being tested in three clinical trials. Our most advanced trial is a Phase 2 study in recurrent ovarian cancer.


Killing Cancer – Saving Lives

Genelux Corporation

27 articles with Genelux Corporation